Tag: mcdermed
SIGN UP FOR OUR NEWS LETTER


Quick Search

Reset

Using PSA Intelligently to Manage Prostate Cancer: Part 2 of 2

Wed 31 Aug 2005

PCRI Insights August, 2005 vol. 8, no. 3 By Jonathan McDermed, Pharm. D., Diagnostic Products Corporation Corollary to Part One In Part One of this article (Insights, August 2003), I reviewed studies that described differences in PSA levels between men who eventually developed, or did not develop, prostate cancer in later life. One of theseRead More ›

Using PSA Intelligently to Manage Prostate Cancer: Part 1 of 2

Sun 31 Aug 2003

Using PSA Intelligently to Manage Prostate Cancer, Part 1 of 2 PCRI Insights August, 2003 vol. 6, no. 3 By Jonathan McDermed, Pharm.D., Diagnostic Products Corporation PSA is the tumor marker of choice to aid in the diagnosis of prostate cancer (PC), to assess prognosis, and to monitor patients treated for this disease. Despite growingRead More ›